Updated Asian consensus guidelines for the diagnosis and management of gastrointestinal stromal tumor (2025) - Summary - MDSpire

Updated Asian consensus guidelines for the diagnosis and management of gastrointestinal stromal tumor (2025)

  • By

  • Hidekazu Hirano

  • Yoichi Naito

  • Tsuyoshi Takahashi

  • Seiichi Hirota

  • Kyoung-Mee Kim

  • Min-Hee Ryu

  • Jian Wang

  • Hui Cao

  • Jian Li

  • Chien-Feng Li

  • Chueh-Chuan Yen

  • Han-Kwang Yang

  • Hwoon-Yong Jung

  • Chun-Nan Yeh

  • Hsiu-Po Wang

  • Li-Tzong Chen

  • Lin Shen

  • Yoon-Koo Kang

  • Toshirou Nishida

  • July 15, 2026

Share

Objective:

To provide updated Asian guidelines for the management of gastrointestinal stromal tumors (GIST).

Approach:
  • Guideline Development: The guidelines were developed through a narrative overview of key considerations in the diagnosis and treatment of GIST, with input from a panel of 19 experts across four domains.
Key Findings:
  • GISTs primarily occur in the stomach (60%) and small intestine (30%).
  • GISTs can also occur in the rectum (5%), esophagus (1%), colon (< 1%), and appendix (< 1%).
  • Immunohistochemistry (IHC) is crucial for confirming GIST diagnosis, with c-KIT and DOG-1 being key markers.
  • GISTs can be histologically classified into spindle cell type (70%), epithelioid cell type (20%), and mixed cell type (10%).
Interpretation:

Limitations:
  • The guidelines were developed through a narrative review rather than a systematic review.
  • Formal grading of the level of evidence was not performed.
Conclusion:

The revised guidelines aim to optimize the management of GIST for Asian patients based on the latest evidence and expert consensus.

Original Source(s)

Related Content